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coefﬁ  cients between the subscales of SF-36 and the CTSI-
JSSH-SS or the CTSI-JSSH-FS ranged from −0.23 to −0.66 
and from −0.19 to −0.63, respectively. The SRMs/effect 
sizes of the CTSI-JSSH-SS and the CTSI-JSSH-FS were 
−0.85/−0.99 and −0.70/−0.61, which indicated that they were 
more than moderately sensitive.
Conclusions.  The CTSI-JSSH has sufﬁ  cient reliability, valid-
ity, and responsiveness to assess the health status in carpal 
tunnel syndrome.
Introduction
Health measurement scales are important patient out-
come tools to measure health status and to evaluate 
medical intervention.1 Recently, several measures for 
the evaluation of upper extremity function have been 
developed.2–5 Some of them are joint-speciﬁ  c measures2,3 
or region-speciﬁ  c measures.4,5 Others are intended to 
evaluate the symptoms and function of the upper ex-
tremity using disease-speciﬁ  c measures.6  Among the 
region-speciﬁ  c measures, the Disability of the Arm, 
Shoulder and Hand (DASH) questionnaire5  and its 
short version (QuickDASH)7 are the most recently de-
vised scales and now are widely used in several coun-
tries, including Japan, Sweden, France, Germany, Spain, 
the Netherlands, Italy, and China.8–16  As one of the 
disease-speciﬁ  c measures, a self-administered question-
naire for the assessment of severity of symptoms and 
functional status in carpal tunnel syndrome was origi-
nally devised by Levine et al.6 This instrument has been 
called by several names, e.g., the Carpal Tunnel Syn-
drome Instrument (CTSI),17  Brigham and Women’s 
Abstract
Background.  The Carpal Tunnel Syndrome Instrument 
(CTSI) is a disease-speciﬁ  c, self-administered questionnaire 
that consists of a symptom severity scale (SS) and a functional 
status scale (FS). The CTSI was cross-culturally adapted and 
developed by the Impairment Evaluation Committee, Japa-
nese Society for Surgery of the Hand (JSSH). The purpose of 
this study was to test the reliability, validity, and responsive-
ness of the Japanese version of the CTSI (CTSI-JSSH).
Methods.  A consecutive series of 87 patients with carpal tun-
nel syndrome completed the CTSI-JSSH, the JSSH version of 
the Disability of the Arm, Shoulder, and Hand questionnaire 
(DASH-JSSH), and the 36-Item Short-Form Health Survey 
(SF-36). Seventy-two of the patients were reassessed for test–
retest reliability 1 or 2 weeks later. Reliability was investigated 
by the reproducibility and the internal consistency. To analyze 
the validity, a factor analysis (principal axis factoring) of the 
CTSI-JSSH and the correlation coefﬁ  cients between the 
CTSI-JSSH and DASH-JSSH were obtained. The responsive-
ness was examined by calculating the standardized response 
mean (SRM; mean change/SD) and effect size (mean change/
SD of baseline value) after carpal tunnel release in 42 
patients.
Results.  Cronbach’s alpha coefﬁ  cients for the CTSI-JSSH-SS 
and the CTSI-JSSH-FS were 0.84 and 0.90, respectively, and 
the intraclass correlation coefﬁ  cients were 0.82 and 0.83, re-
spectively. The unidimensionality of the CTSI-JSSH-SS was 
barely conﬁ  rmed; the unidimensionality of the CTSI-JSSH-FS 
was conﬁ  rmed. The correlation coefﬁ  cients between the CTSI-
JSSH-FS and the CTSI-JSSH-SS or DASH-JSSH were 0.58 
and 0.80, respectively. The correlation coefﬁ  cient between the 
CTSI-JSSH-SS and DASH-JSSH was 0.54. The correlation 
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Carpal Tunnel Questionnaire,18 and the Boston Carpal 
Tunnel Syndrome Questionnaire.19  We adopted the 
CTSI for the current study. The CTSI is now available 
in a few languages and has been used in several coun-
tries (e.g., Sweden,17  Spain,13  Italy,20  and the Nether-
lands21). The only studies of reliability and validity of 
the CTSI that have been published are for the original 
CTSI6 and for the Swedish version.17
We, the Impairment Evaluation Committee of the 
Japanese Society for Surgery of the Hand (JSSH), have 
completed cross-cultural adaptation and have devel-
oped the JSSH version of the CTSI (CTSI-JSSH).22 The 
purpose of this study was to test the reliability, validity, 
and responsiveness of the CTSI-JSSH and to make the 
CTSI-JSSH available for use in Japan.
Materials and methods
In accordance with published guidelines,23 we set up the 
CTSI-JSSH committee and recruited translators, re-
searchers, a methodologist, and a Japanese language 
expert, and culturally adapted the CTSI into Japanese, 
as had been done for DASH-JSSH.8
The adaptation process
The English version of the CTSI6 was translated into 
Japanese by two translators whose ﬁ  rst language was 
Japanese. One of them had no medical background and 
the other did have a medical background. Their two 
“forward” translations were synthesized into one ver-
sion after being reviewed and discussed by the commit-
tee. This Japanese version (the preﬁ  nal version) was 
translated back into English by two other translators 
whose ﬁ  rst language was English. One of them was 
blinded to the concepts being investigated and had no 
medical background; the other had a medical back-
ground. After we compared these two back-translations 
with the original CTSI, we developed the CTSI-JSSH 
(preﬁ  nal version 2). Then we commenced the pilot test. 
After analyzing the pilot test data, we modiﬁ  ed preﬁ  nal 
version 2 of the CTSI-JSSH into a ﬁ  nal version. The 
ﬁ  nal CTSI-JSSH version22  was then evaluated with 
regard to reliability, validity, and responsiveness.
The CTSI questionnaire
The CTSI questionnaire developed by Levine et al.6 
contains two subscales: a symptom severity scale (CTSI-
SS) (Table 1) and a functional status scale (CTSI-FS) 
(Table 2).
The CTSI-SS consists of eleven items which were 
derived from six clinical domains for carpal tunnel syn-
drome: pain (three items, numbers 3–5), paresthesia 
(one item, number 8), numbness (one item, number 6), 
weakness (one item, number 7), nocturnal symptoms 
(four items, numbers 1,2,9,10), and overall functional 
status (one item, number 11). The eleven questions 
have multiple-choice responses, scored from 1 point (no 
symptom) to 5 points (most severe symptom). The over-
all symptom severity score is calculated as the mean of 
the scores for the eleven individual items.
The CTSI-FS consists of eight functional activities 
commonly affected by carpal tunnel syndrome. The 
answers are rated from 1 point (no difﬁ  culty with the 
activity) to 5 points (cannot perform the activity at all). 
The overall score for functional status is calculated as 
the mean of all eight items.
Patients and setting
The study was conducted on a consecutive series of 87 
patients (15 men, 66 women) with a clinical diagnosis of 
carpal tunnel syndrome seen on an outpatient or inpa-
tient basis in ﬁ  ve orthopedic surgery departments in 
Japan. The mean age was 58.3 years (SD 13.8 years, 
range 21–86 years). After informed consent was ob-
tained from the patients to participate in this study, they 
answered the CTSI-JSSH questionnaire,22  the JSSH 
version of the DASH (DASH-JSSH) questionnaire,8  Table 1.  Symptom severity scale of the Carpal Tunnel Syn-
drome Instrument
Item code  Scale item
SS-1  Severity of nocturnal pain
SS-2  Frequency of nocturnal awakening due to pain
SS-3  Severity of daytime pain
SS-4  Frequency of daytime pain
SS-5  Duration of daytime pain
SS-6 Severity  of  numbness
SS-7 Severity  of  weakness
SS-8 Severity  of  tingling
SS-9  Severity of nocturnal numbness or tingling
SS-10    Frequency of nocturnal awakening due to 
  numbness or tingling
SS-11 Difﬁ  culty with grasping and use of small objects
Table 2.  Functional status scale of the Carpal Tunnel Syn-
drome Instrument
Item code  Scale item
FS-1 Writing
FS-2 Buttoning  clothes
FS-3  Holding a book while reading
FS-4  Gripping the telephone receiver
FS-5 Opening  jars
FS-6 Performing  household  chores
FS-7  Carrying of grocery bags
FS-8 Bathing  and  dressing16  T. Imaeda et al.: Validation of the JSSH version of the CTSI
the ofﬁ  cial Japanese version of the 36-Item Short-Form 
Health Survey (SF-36, version 1.2),24  and the Visual 
Analog Scale (VAS) (0–10 scale) for pain. The data 
collected from the 87 patients were used as a baseline 
value. Among the 87 patients, the 72 who had received 
no treatment such as medication or rehabilitation dur-
ing the consecutive visits were readministered the CTSI-
JSSH questionnaire 1 or 2 weeks later. The 45 patients 
who underwent carpal tunnel release answered the 
CTSI-JSSH and the DASH-JSSH questionnaires twice, 
once preoperatively and once postoperatively, 3 months 
after surgery. The protocol of this study was reviewed 
and approved by the institutional review boards prior 
to implementation.
Assessment of reliability, validity, and responsiveness
Reliability was investigated by looking at the reproduc-
ibility and internal consistency based on the test–retest 
method. The following analyses were conducted to ex-
amine the validity. A factor analysis (principal axis fac-
toring) was conducted to examine the construct validity 
and the unidimensionality of the CTSI-JSSH-SS and 
CTSI-JSSH-FS. The completeness of item responses for 
the CTSI-JSSH was examined.
Correlation coefﬁ  cients between the CTSI-JSSH (SS 
and FS) and DASH-JSSH were obtained, and the fol-
lowing hypotheses were examined to investigate con-
current validity: (1) the CTSI-JSSH-SS would exhibit a 
moderate association with DASH-JSSH; (2) the CTSI-
JSSH-FS would exhibit the strongest association with 
DASH-JSSH.
Correlation coefﬁ  cients between the CTSI and SF-36 
were also obtained, and the following hypotheses were 
examined to investigate concurrent validity: (1) the 
CTSI-JSSH-SS would exhibit the strongest association 
with “bodily pain” (SF-36-BP) among the SF-36 sub-
scales; (2) the CTSI-JSSH-FS would exhibit the stron-
gest association with “physical functioning” (SF-36-PF) 
or “role-physical” (SF-36-RP). These three subscales of 
SF-36 were chosen because the correlation between 
DASH-JSSH and the three subscales of SF-36 was more 
than moderate.8
The responsiveness of both the CTSI-JSSH and 
DASH-JSSH were examined by calculating the stan-
dardized response mean (SRM; mean change/SD)25 and 
the effect size (mean change/SD of baseline value)26 
after carpal tunnel release.
Statistical analysis
The distributions of the CTSI-JSSH, DASH-JSSH, SF-
36, VAS for pain, the ages of the subjects, and the time 
required to ﬁ  ll out the CTSI-JSSH questionnaire were 
assessed. The interval measurements (CTSI-JSSH-SS, 
CTSI-JSSH-FS, DASH-JSSH, SF-36-BP, age) were 
normally distributed and the other interval measure-
ments (SF-36-PF, SF-36-RP, VAS for pain, and time 
required to ﬁ  ll out the questionnaire of the CTSI-JSSH) 
were not normally distributed. Then Cronbach’s alpha 
was used to assess internal consistency of the CTSI-
JSSH (SS and FS). The instrument test–retest reliability 
of CTSI-JSSH (SS and FS) was assessed with the intra-
class correlation coefﬁ  cient (ICC). All correlation co-
efﬁ  cients among the CTSI-JSSH, DASH-JSSH, and 
SF-36 results were calculated with use of Spearman’s 
rank correlation coefﬁ  cient. The changes in measure-
ments after carpal tunnel release were assessed with a 
parametric test (paired t test). All statistical analyses 
were conducted using the Statistical Package for Social 
Science (SPSS) version 14.0J software (SPSS Japan, 
Tokyo). The critical values for signiﬁ  cance were set at 
P < 0.05.
Results
Completeness of item responses
No patients had difﬁ  culty completing the CTSI-JSSH 
questionnaire. It took them 5  min 40  s, on average, to 
ﬁ  nish the questionnaire (median: 5 min, range: 2–30 min). 
Most of the patients considered all the items of the CTSI 
to be clear. Nine of the 72 patients (nonrespondent 
group) did not answer one or more items of the CTSI. 
Two of these patients failed to answer more than two 
items, with each leaving four items unanswered. Items 
5, 7, and 8 of the CTSI-JSSH-SS were left unanswered 
by one patient each. Three patients did not answer items 
1 and 3 of the CTSI-JSSH-FS. Two patients did not re-
spond to item 7 of the CTSI-JSSH-FS. Items 2, 4, 6, and 
8 of CTSI-JSSH-FS were each unanswered by one pa-
tient. The mean age [70 ± 12 (SD) years] of the nonre-
spondent group (n = 9) was signiﬁ  cantly larger than the 
mean age (57 ± 13 years) of the respondent group (n = 
78) who completed all the items (P = 0.008).
The mean, median, SD, and range of the CTSI-JSSH, 
DASH-JSSH, SF-36, and VAS for pain scores are shown 
in Table 3. The number of ceiling scores in the CTSI-
JSSH were identiﬁ  ed. One and ﬁ  ve patients had the 
minimum disability score of zero (ceiling) on the CTSI-
JSSH-SS and the CTSI-JSSH-FS, respectively. No pa-
tient had a maximum disability score of 5 (ﬂ  oor) either 
on the CTSI-JSSH-SS or on the CTSI-JSSH-FS.
Reliability
Internal consistency was assessed by use of Cronbach’s 
alpha coefﬁ  cient. The alpha coefﬁ  cient for the 11 items 
in the CTSI-JSSH-SS was 0.839 (n = 84). When the al-T. Imaeda et al.: Validation of the JSSH version of the CTSI  17
pha coefﬁ  cient was calculated for each of the 11 items 
by eliminating each item, one by one, the range was 
0.814–0.838; no item was found to change the internal 
consistency substantially. The alpha coefﬁ  cient for the 
8 items of the CTSI-JSSH-FS was 0.900 (n = 82). When 
the alpha coefﬁ  cient was calculated for each of the 8 
items by eliminating each item, one by one, the range 
was 0.879–0.900; no item was found to change the inter-
nal consistency substantially.
Instrument test–retest reliability was assessed with 
the intraclass correlation coefﬁ  cient (ICC). There were 
72 patients involved in the assessment of test–retest reli-
ability, and the period between the ﬁ  rst and second tests 
was on average 10.7 days (SD 6.0 days). The ICCs for 
the CTSI-JSSH-SS and the CTSI-JSSH-FS were 0.82 
(95%CI: 0.79–0.89) and 0.83 (95%CI: 0.74–0.89), re-
spectively. Both ICCs for the CTSI-JSSH subscales 
indicate sufﬁ  cient reproducibility.
Validity
A factor analysis (principal axis factoring) was con-
ducted to conﬁ  rm the unidimensionality of the CTSI-
JSSH-SS and the CTSI-JSSH-FS. The ﬁ  rst factor of the 
CTSI-JSSH-SS had an eigenvalue (amount of variation 
in the total sample accounted for by that factor)14 of 
4.44, which explained 40% of the total variance of the 
CTSI-JSSH-SS scores of the patients (Fig. 1). The sec-
ond factor of the CTSI-JSSH-SS had an eigenvalue of 
1.86, which explained 17% of the total variance of the 
CTSI-JSSH-SS scores of the patients, these two factors 
thus explain 57% of the cumulative variance of the 
CTSI-JSSH-SS scores of the patients (Fig. 1). Factor 
analysis indicated the presence of at least two factors 
in the CTSI-JSSH-SS, which means bidimensionality. 
Next, further factor analysis (principal axis factoring set 
for two factors, rotation: promax) was conducted. When 
looking at the ﬁ  rst factor loading for each item, some 
items (items 1, 2, 6, 9, 10, and 11) had a loading (the 
correlation with the total score) of 0.4 or higher (Table 
4). When looking at the second factor loading for each 
item, some items (items 3, 4, and 5) had a loading of 0.4 
or higher (Table 4). When we adopted one factor to 
conduct factor analysis (principal axis factoring) of the 
CTSI-JSSH-SS, the loading of all factors was more than 
0.4, except for item 11.
The ﬁ  rst factor of the CTSI-JSSH-FS had an eigen-
value of 4.79, which explained 60% of the total variance 
of the CTSI-JSSH-FS scores of the patients (Fig. 2). The 
unidimensionality of the CTSI-JSSH-FS was found to 
be strong as a result of the low eigenvalue of the second 
Table 3.  Mean scores and range of scores for CTSI, DASH, SF-36, and VAS
Instrument scale (n) Mean  SD  Median Minimum Maximum
CTSI-JSSH-SS  (87)   2.53   0.72   2.54  1.00a      4.27
CTSI-JSSH-FS  (87)   2.20   0.80   2.00  1.00a      4.00
DASH-JSSH (79)  31.2  18.3  27.5  0a    74.1
SF-36-PF (77)  65.2  29.2  75.0  0b  100a
SF-36-RP (66)  56.6  40.2  75.0  0b  100a
SF-36-BP (77)  44.9  19.9  41.0  0b  100a
VAS  (77)   3.4   3.0   3.0  0a   10b
CTSI-JSSH-SS, the symptom severity scale of the Japanese Society for Surgery of the Hand 
version of the Carpal Tunnel Syndrome Instrument (CTSI-JSSH); CTSI-JSSH-FS, the functional 
status scale of the CTSI-JSSH; DASH-JSSH, the disability/symptom scale of the Japanese 
version of the Disability of the Arm, Shoulder, and Hand questionnaire; SF-36-PF, physical 
functioning subscale of the 36-Item Short-Form Health Survey (SF-36); SF-36-RP, role-physical 
subscale of SF-36; SF-36-BP, bodily pain subscale of SF-36; VAS, Visual Analog Scale for pain 
(0–10 scale)
a Maximum health status scores (ceiling)
b Minimum health status scores (ﬂ  oor)
Fig. 1.  Scree plot of the factors in the symptom severity scale 
of the Japanese Society for Surgery of the Hand version of 
the Carpal Tunnel Syndrome Instrument (CTSI-JSSH)18  T. Imaeda et al.: Validation of the JSSH version of the CTSI
factor (0.96, Fig. 2). When looking at the ﬁ  rst factor 
loading for each item, all items had a loading of 0.4 or 
higher.
The correlation coefﬁ  cients between the CTSI-JSSH-
SS and the CTSI-JSSH-FS or the DASH-JSSH were 
0.58 and 0.54, respectively (Table 5, P < 0.01). These 
results indicate a moderate correlation between the 
CTSI-JSSH-SS and the CTSI-JSSH-FS, and between 
the CTSI-JSSH-SS and DASH-JSSH. The correlation 
coefﬁ  cient between the CTSI-JSSH-FS and DASH-
JSSH was 0.80 (Table 5, P < 0.01), which indicates a 
strong correlation between them. These results support 
the hypotheses set down in advance.
The correlations between the CTSI-JSSH-SS score 
and the subscales of the SF-36 scale ranged from −0.23 
to −0.66 (Table 5). The strongest correlation was ob-
served for “bodily pain.” The correlation between the 
CTSI-JSSH-SS and “role-physical” or “physical func-
tioning” were somewhat weak. These results support 
the hypotheses set down in advance.
The correlations between the CTSI-JSSH-FS score 
and the subscales of the SF-36 scale ranged from −0.19 
to −0.63 (Table 5). The strongest correlation was ob-
served for “bodily pain” followed by “role-physical.” 
The correlation between the CTSI-JSSH-FS and “phys-
ical functioning” was somewhat weak. These results 
contradicted the hypotheses set down in advance, ex-
cept for “role-physical.”
No statistical difference (P = 0.904) in age was found 
between men [mean (SD): 60 (12) years] and women 
[mean (SD): 59 (13) years]. The CTSI-JSSH-SS scores 
for men [mean (SD): 2.68 (0.80)] and women [mean 
(SD): 2.49 (0.68)] were compared by Student’s t test. 
There was no statistical difference between them 
(P = 0.29). The CTSI-JSSH-FS scores for men [mean 
(SD): 2.40 (0.80)] and women [mean (SD): 2.21 (0.74)] 
were similarly compared and there was no statistical 
difference between them (P = 0.37). These results sup-
port our hypothesis. The correlation between age and 
the CTSI-JSSH-SS or the CTSI-JSSH-FS score was 
Table 4.  Pattern matrix (rotated, promax) of factor analysis 
for CTSI-SS
  Component
Item 1  2
CTSI-SS-2  0.827
CTSI-SS-9  0.805
CTSI-SS-10  0.795
CTSI-SS-6  0.607
CTSI-SS-1  0.542  0.324
CTSI-SS-11  0.415
CTSI-SS-7 0.319  0.204
CTSI-SS-8 0.271  0.222
CTSI-SS-4   1.042
CTSI-SS-5   0.771
CTSI-SS-3   0.746
Loadings of more than 0.2 are shown in this table
Bold ﬁ  gures indicate values greater than 0.4
Fig. 2.  Scree plot of the factors in the functional status scale 
of CTSI-JSSH
Table 5.  CTSI, DASH, SF-36, VAS and their correlation
  Correlationa with
Instrument scale (n) CTSI-JSSH-SS  (87) CTSI-JSSH-FS DASH-JSSH
CTSI-JSSH-FS (87)    0.58**  —  —
DASH-JSSH (79)    0.54**    0.80**  —
SF-36-PF (77)  −0.23  −0.19  −0.34**
SF-36-RP (66)  −0.29*  −0.50**  −0.71**
SF-36-BP (77)  −0.66**  −0.63**  −0.68**
VAS  (77)   0.40**   0.23*   0.32**
* P < 0.05
** P < 0.01
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weak (r  =  −0.041,  P  =  0.704;  r  =  0.014,  P  =  0.898, 
respectively).
The correlation between the CTSI-JSSH-SS score 
and VAS for pain was moderate but the correlation 
between the CTSI-JSSH-FS score and VAS for pain 
was weak (Table 5).
Responsiveness
Forty-two patients of the 45 who underwent carpal tun-
nel release completed the CTSI-JSSH and the DASH-
JSSH questionnaires at 3 months (mean: 96 days, SD: 9 
days) after the surgery. The mean subject age was 62 
years (SD: 14 years, range: 21–86 years). There were 5 
men and 37 women. The calculated standardized re-
sponse mean (SRM) and effect size for CTSI-JSSH-SS 
(n = 42), CTSI-JSSH-FS (n = 42), and DASH-JSSH (n 
= 40) was −0.85/−0.99, −0.70/−0.61, and −0.35/−0.36, re-
spectively. There were statistical differences between 
the mean value of preoperative and postoperative 
CTSI-JSSH-SS scores (P < 0.001), CTSI-JSSH-FS scores 
(P < 0.001), and DASH-JSSH scores (P = 0.034).
Discussion
Adaptation of the CTSI questionnaire for Japanese pa-
tients was performed following a systematic standard-
ized approach.23  The purpose of this study was to 
examine the psychometric qualities of the CTSI by as-
sessing its psychometric standards in the areas of reli-
ability, validity, and responsiveness.
The CTSI consists of an 11-item symptom severity 
scale and an 8-item functional status scale. It took pa-
tients a shorter time to complete the CTSI-JSSH com-
pared with the time to complete the DASH-JSSH.8 This 
indicated that the questionnaire was easy to understand. 
Most older patients left no more than two items unan-
swered and those were thought to be pertaining to spe-
ciﬁ  c activities that those individuals did not perform. 
The lack of ﬂ  oor effects assures the authors of the valid-
ity of both subscales of the CTSI-JSSH.
As for internal consistency, the Cronbach’s alpha co-
efﬁ  cients for CTSI-JSSH-SS (0.83) and CTSI-JSSH-FS 
(0.90) were equivalent to those of the original version 
of the CTSI (SS: 0.89, FS: 0.91)6 and those of the Swed-
ish version of the CTSI (SS: 0.80, FS: 0.87).17 As for re-
producibility, the ICC of the CTSI-JSSH-SS (0.82) and 
the CTSI-JSSH-FS (0.83) were not equivalent to the 
Pearson correlation coefﬁ  cients of the original version 
of the CTSI (SS: 0.91, FS: 0.93)6 but were equivalent to 
the Pearson correlation coefﬁ  cients of the Swedish ver-
sion of the CTSI (SS: 0.80, FS: 0.87).17 Therefore the 
results for the internal consistency and reproducibility 
of the CTSI-JSSH indicate sufﬁ  cient reliability.
As for measurement precision, recommended reli-
ability standards for individual-level applications range 
from a low of 0.90 to a high of 0.95, which is the desired 
standard.27 Most general health status measures [e.g., 
SF-36, the Nottingham Health Proﬁ  le (NHP), and the 
Functional Status Questionnaire (FSQ)],27  as well as 
lesion- or joint-speciﬁ  c questionnaires [e.g., the Roland-
Morris Disability Questionnaire28  and the Western 
Ontario and McMaster Universities osteoarthritis 
index (WOMAC)] cannot meet this standard, whether 
they are designed for individual patient applications or 
group-level applications. Most translated DASH ver-
sions8,10,12–15 as well as the original DASH29 have internal 
consistency values higher than 0.95 and meet this stan-
dard. But the symptom severity scale and functional 
status scale of the CTSI-JSSH had internal consistency 
values of 0.84 and 0.90. We would thus prefer that the 
CTSI-JSSH be used for groups of patients or workers.
There are many types of validation processes of qual-
ity of life (QOL) questionnaires. The present study ad-
opted correlation between CTSI-JSSH and other QOL 
questionnaires such as SF-36 and DASH. Although 
Levine et al.6 and Atroshi et al.17 did not demonstrate 
those correlations, Gay et al.30 studied the correlation 
between the original DASH and the original CTSI 6 
weeks after carpal tunnel release. The correlation 
coefﬁ  cients between the CTSI-SS and the CTSI-FS or 
DASH were 0.74 and 0.88 respectively.30 The validation 
process of the CTSI-JSSH questionnaire has shown that 
it has lower validity than the original CTSI.30 The strong 
correlations between the CTSI-JSSH and DASH-JSSH 
support the validity of CTSI-JSSH (Table 5). The mod-
erate correlations between the CTSI-JSSH and SF-36 
subscales (physical functioning and bodily pain) also 
support this validity. These results demonstrate that the 
CTSI-JSSH measures the important elements that make 
up health-related QOL.
Another validation method is factor analysis, which 
was not adopted in other validation studies of the 
CTSI.6,17 The symptom severity scale of the CTSI-JSSH 
exhibited bidimensionality (Table 4, Fig. 1). The two 
factors could be identiﬁ  ed from this table. The second 
factor is “daytime pain” (items 3–5). The ﬁ  rst factor is 
other symptoms such as nocturnal symptoms (items 1, 
2, 9, 10), numbness (item 6), weakness (item 7), pares-
thesia (item 8), and overall functional status (item 11). 
Atroshi et al.17 divided the symptom severity scale into 
two components: the pain component (items 1–5) and 
the sensory component (items 6 and 8–11), and success-
fully demonstrated that the responsiveness of the sen-
sory component is larger than that of the pain component, 
although they did not conduct a factor analysis. Theo-
retically, overall functional status (item 11 of symptom 
severity) could be included in the functional status scale. 
These results show that the symptom severity scale of 20  T. Imaeda et al.: Validation of the JSSH version of the CTSI
the CTSI-JSSH could be divided into two. If we adopt 
one factor for the symptom severity scale of the CTSI-
JSSH, it barely maintains unidimensionality from the 
results of factor loading. This means that the symptom 
severity scale of the CTSI-JSSH has a high quality of 
validation.
The functional status scale of the CTSI-JSSH exhib-
ited high unidimensionality and there was no low item-
scale correlation. The loading of this scale was very 
high. These results show that the functional status scale 
of the CTSI-JSSH has a high quality of validation.
Cohen’s rule of thumb for interpreting the “effect size 
index” (i.e., a value of 0.2 is small, 0.5 is moderate, and 
0.8 or greater is large) can be applied to the SRM.25 The 
responsiveness of the symptom severity scale and func-
tional status scale of the CTSI-JSSH for patients with 
carpal tunnel syndrome was large and moderate, re-
spectively, 3 months after carpal tunnel release opera-
tion, although other studies of the CTSI17,30  showed 
twice the responsiveness levels of our results. The re-
sponsiveness levels of both subscales of CTSI-JSSH 
were twice that of DASH-JSSH. Gay et al.30 also de-
scribed similar ﬁ  ndings. Moreover, there were statistical 
differences between the mean value of preoperative 
and postoperative subscale scores for the CTSI-JSSH.
We believe that the strengths of this study are that 
the CTSI-JSSH demonstrated good reproducibility, 
consistency, and validity. Moreover, it had at least mod-
erate responsiveness. A limitation of the present study 
is that we could not successfully demonstrate the re-
sponsiveness of the CTSI-JSSH because the sample size 
was relatively small and the patients’ response rate was 
low. Moreover, the subjects of this study are not repre-
sentative of the general population.
Conclusions
We can conclude that the Japanese Society for Surgery 
of the Hand version of the Carpal Tunnel Syndrome 
Instrument (CTSI-JSSH) has sufﬁ  cient reliability, valid-
ity, and responsiveness to assess the severity of symp-
toms and the functional status in carpal tunnel syndrome. 
Above all, the CTSI-JSSH can be used for groups of 
patients.
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